AI Agents in Drug Discovery 2026
Please join TandemAI for: AI Agents in Drug Discovery-2026. Our forum will include senior pharma and biotech leaders who are working at the intersection of AI/ML, physics based computation and drug discovery. Through keynote presentations and panel discussions, the program will explore how agents are reshaping the path from target ID to therapeutic candidate. Attendees will hear perspectives from across modalities and across the discovery pipeline – from people who can really speak to what’s working with agentic workflows, what isn’t working, and where the field is headed.
Program:
2:00-3:00 PM – Registration/Networking
3:00-3:30 PM – 24/7 Drug Hunter: Building Autonomous Scientific Workflows on Structured Experimental Data – Mitchell Buckley, Head of Partnerships - CDD Vault, Frederick Parsons, Sr. Director, Head of AI Platform & Product - TandemAI
3:30-4:00 PM – Enterprise Lab in the Loop - Sanofi's Scientific Workflow Experience Labs - Pradeep Bandaru, Head of Platforms and AI Workflows – Sanofi
4:00-4:30 PM – AI Agents in Drug Design, a Recursion Perspective - Donovan Chin, SVP Drug Design – Recursion
4:30-5:00 PM – Embracing Agents at TandemAI - Brian Chamberlain, AVP, US Head of Medicinal Chemistry - TandemAI
5:00-5:30 PM – Seeing further? Agentic Drug Discovery and It's Limits - Jacob Oppenheim, Venture Partner - RA Ventures
5:30-6:30 PM - Panel Discussion: The Intersection of AI/ML and Drug Discovery: How Agents are Reshaping the Path from Target ID to Therapeutic Candidate
Jörg Bentzien – Director, Computational Chemistry - Alkermes
Aaron Frank – Sr. Director Head of Computational Drug Discovery - Parabilis Medicines
Tamsin Mansley – Principal - Mansley Scientific
Soumya Ray – Co-Founder & Chief Innovation Officer – Passkey Therapeutics
6:30-8:00 PM - Dinner Reception & Networking